Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib


AÇIKALIN A. , BAĞIR KILIÇ E. , PAYDAŞ S. , ALSANCAK P. , ERGİN M.

CUKUROVA MEDICAL JOURNAL, cilt.44, ss.395-401, 2019 (ESCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 44 Konu: 2
  • Basım Tarihi: 2019
  • Doi Numarası: 10.17826/cumj.442276
  • Dergi Adı: CUKUROVA MEDICAL JOURNAL
  • Sayfa Sayıları: ss.395-401

Özet

Purpose: Multiple myeloma is a heterogeneous disease, for which an understanding of the prognostic and predictive value of chromosomal aberrations is necessary to prescribe the most appropriate therapy. We aimed to document the frequencies of chromosomal aberrations in our institute and searched the relationships between therapy regimens and chromosomal aberrations.